Growth Metrics

Gilead Sciences (GILD) Tax Rate (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 4,332.00
Dec 31, 2025 -3,783.00
Sep 30, 2025 -309.00
Jun 30, 2025 -99.00
Mar 31, 2025 249.00
Dec 31, 2024 4,883.00
Sep 30, 2024 -5,240.00
Jun 30, 2024 1,431.00
Mar 31, 2024 -732.00
Dec 31, 2023 804.00
Sep 30, 2023 -2,827.00
Jun 30, 2023 1,026.00
Mar 31, 2023 471.00
Dec 31, 2022 -697.00
Sep 30, 2022 208.00
Jun 30, 2022 -8,341.00
Mar 31, 2022 5,743.00
Dec 31, 2021 2,568.00
Sep 30, 2021 827.00
Jun 30, 2021 -743.00
Mar 31, 2021 906.00
Dec 31, 2020 -4,233.00
Sep 30, 2020 6,976.00
Jun 30, 2020 -3,576.00
Mar 31, 2020 -3,991.00
Dec 31, 2019 4,094.00
Sep 30, 2019 -1.00
Jun 30, 2019 594.00
Mar 31, 2019 -4,162.00
Dec 31, 2018 3,667.00
Sep 30, 2018 841.00
Jun 30, 2018 -1,150.00
Mar 31, 2018 -24,851.00
Dec 31, 2017 24,669.00
Sep 30, 2017 70.00
Jun 30, 2017 4.00
Mar 31, 2017 444.00
Dec 31, 2016 -130.00
Sep 30, 2016 174.00
Jun 30, 2016 -26.00
Mar 31, 2016 694.00
Dec 31, 2015 -225.00
Sep 30, 2015 -232.00
Jun 30, 2015 109.00
Mar 31, 2015 -84.00
Dec 31, 2014 -104.00
Sep 30, 2014 396.00
Jun 30, 2014 -938.00
Mar 31, 2014 -469.00
Dec 31, 2013 204.00
Sep 30, 2013 -136.00
Jun 30, 2013 497.00
Mar 31, 2013 -207.00
Dec 31, 2012 -371.00
Sep 30, 2012 227.00
Jun 30, 2012 -740.00
Mar 31, 2012 1,540.00
Dec 31, 2011 -517.00
Sep 30, 2011 -8.00
Jun 30, 2011 -155.00
Mar 31, 2011 433.00
Dec 31, 2010 -528.00
Sep 30, 2010 -166.00
Jun 30, 2010 207.00
Mar 31, 2010 6,937.00
Dec 31, 2009 -6,760.00
Sep 30, 2009 10.00
Jun 30, 2009 -162.00